Brief: Gabather receives patent in India for l1001c triazoloderivat
03/10/2017 07:57
Oct 3 (Reuters) - GABATHER AB GABAT.ST
* RECEIVED PATENT FROM INDIAN PATENT OFFICE FOR COMPANY'S
PATENT FAMILY, L1001C TRIAZOLODERIVAT, IN WHICH SUBSTANCE GT-002
IS DESCRIBED. PATENT IS VALID UNTIL 2029
Source text for Eikon: ID:nWkr32FCRx
Further company coverage: GABAT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))